Literature DB >> 26557955

Human immunodeficiency virus and viral hepatitis among high-risk groups: Understanding the knowledge gap in the Middle East and North Africa Region.

Nada M Melhem1, Nour Rahhal1, Rana Charide1, Khalil Kreidieh1, Rolla El-Khatib1.   

Abstract

AIM: To identify gaps in the existing knowledge on single, dual and triple infections of human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) in the Middle East and North Africa (MENA) region among men who have sex with men (MSMs), female sex workers (FSWs), injecting drug users (IDUs) and prisoners.
METHODS: We performed an extensive literature search on articles published on the topic in the 25 countries of the MENA region. PubMed database was used as the main search engine. Case reports, case series, qualitative studies, editorials, commentaries, authors' replies and animal studies were excluded. Original articles and reviews dealing with the prevalence of HIV, HBV and HCV and their co-infection were included. Data on population type, sample size, age and markers of infections were extracted from the relevant studies.
RESULTS: HIV, HBV and HCV are blood-borne viruses with similar modes of transmission. The categories of people at high risk of acquiring HIV-1, HBV and HCV commonly include: MSMs, FSW and IDUs. It is well established that HIV-positive individuals co-infected with HBV or HCV suffer from liver pathology associated with morbidity and mortality. Moreover, HIV-infected individuals do not respond well to treatment for HBV or HCV and hence are at increased risk of hepatic toxicity. Consequently, co-infection of HIV-positive individuals with HBV and/or HCV is a global health problem of significant magnitude. Our review reveals the paucity of epidemiological data for key populations in many countries of the region. Limited number of studies exists in the MENA region on the status of HIV, HBV and HCV and their co-infections among prisoners, MSMs and FSWs. Evidence support the continued increase of the HIV epidemic among MSMs. In addition to the lack of studies on MSMs and FSWs in the MENA region, our review highlights the lack of data on the practices, characteristics, or the status of HIV infection and viral hepatitis among male sex workers selling or exchanging sex for money.
CONCLUSION: The MENA countries are in urgent need of advanced research and strengthening of the data collection systems and reporting practices of these infections among key populations.

Entities:  

Keywords:  Female sex workers; Hepatitis B virus; Hepatitis C virus; Human immunodeficiency virus; Injecting drug users; Men who have sex with men; Prisoners

Year:  2015        PMID: 26557955      PMCID: PMC4635148          DOI: 10.4254/wjh.v7.i25.2619

Source DB:  PubMed          Journal:  World J Hepatol


  72 in total

Review 1.  Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.

Authors:  Paul K Nelson; Bradley M Mathers; Benjamin Cowie; Holly Hagan; Don Des Jarlais; Danielle Horyniak; Louisa Degenhardt
Journal:  Lancet       Date:  2011-07-27       Impact factor: 79.321

2.  Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran.

Authors:  Saman Zamani; Ramin Radfar; Pardis Nematollahi; Reza Fadaie; Marjan Meshkati; Shahrzad Mortazavi; Abbas Sedaghat; Masako Ono-Kihara; Masahiro Kihara
Journal:  Int J Drug Policy       Date:  2010-05-18

3.  Viral hepatitis and HIV infection among injection drug users in a central Iranian City.

Authors:  Masoomeh Sofian; Arezoo Aghakhani; Mohammad Banifazl; Kayhan Azadmanesh; Ali-Asghar Farazi; Willi McFarland; Ali Eslamifar; Amitis Ramezani
Journal:  J Addict Med       Date:  2012-12       Impact factor: 3.702

4.  Distribution of hepatitis C virus genotypes among injecting drug users in Lebanon.

Authors:  Ziyad Mahfoud; Kassem Kassak; Khalil Kreidieh; Sarah Shamra; Sami Ramia
Journal:  Virol J       Date:  2010-05-13       Impact factor: 4.099

5.  The prevalence rate of hepatitis B and hepatitis C co-infection in HIV positive patients in Mazandaran province, Iran.

Authors:  Farhang Babamahmoodi; Mohammad Ali Heidari Gorji; Mohammad Mahdi Nasehi; Leila Delavarian
Journal:  Med Glas (Zenica)       Date:  2012-08

6.  Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: seroprevalence, risk factors and related chronic liver diseases.

Authors:  Hala I Mohamed; Zienab M Saad; Ehab M Abd-Elreheem; Wael M Abd-ElGhany; Mohamed S Mohamed; Emad A Abd Elnaeem; Amany E Seedhom
Journal:  J Infect Public Health       Date:  2013-02-27       Impact factor: 3.718

7.  HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.

Authors:  Afarin Rahimi-Movaghar; Emran M Razaghi; Elaheh Sahimi-Izadian; Masoumeh Amin-Esmaeili
Journal:  Int J Infect Dis       Date:  2009-05-21       Impact factor: 3.623

8.  Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.

Authors:  Sedigheh Amini Kafi-abad; Houri Rezvan; Hassan Abolghasemi; Ali Talebian
Journal:  Transfusion       Date:  2009-06-10       Impact factor: 3.157

9.  Impact of hepatitis C on survival of HIV-infected individuals in Shiraz; South of Iran.

Authors:  Abbas Rezaianzadeh; Jafar Hasanzadeh; Abbas Alipour; Mohamed Ali Davarpanah; Abdorreza Rajaeifard; Seyed Hamid Reza Tabatabaee
Journal:  Hepat Mon       Date:  2012-02-29       Impact factor: 0.660

10.  Seroprevalence of HIV, HBV and HCV in Persons Referred to Hamadan Behavioral Counseling Center, West of Iran.

Authors:  F Keramat; P Eini; M M Majzoobi
Journal:  Iran Red Crescent Med J       Date:  2011-01-01       Impact factor: 0.611

View more
  10 in total

Review 1.  HIV infection and immune activation: the role of coinfections.

Authors:  Afroditi Boulougoura; Irini Sereti
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

Review 2.  Reconstruction of the origin and dispersal of the worldwide dominant Hepatitis B Virus subgenotype D1.

Authors:  Nídia Sequeira Trovão; Marijn Thijssen; Bram Vrancken; Andrea-Clemencia Pineda-Peña; Thomas Mina; Samad Amini-Bavil-Olyaee; Philippe Lemey; Guy Baele; Mahmoud Reza Pourkarim
Journal:  Virus Evol       Date:  2022-04-08

3.  Factors influencing immunologic response to hepatitis B vaccine in adults.

Authors:  Shigui Yang; Guo Tian; Yuanxia Cui; Cheng Ding; Min Deng; Chengbo Yu; Kaijin Xu; Jingjing Ren; Jun Yao; Yiping Li; Qing Cao; Ping Chen; Tiansheng Xie; Chencheng Wang; Bing Wang; Chen Mao; Bing Ruan; Tian'an Jiang; Lanjuan Li
Journal:  Sci Rep       Date:  2016-06-21       Impact factor: 4.379

4.  Evaluation of response to hepatitis B vaccine in Iranian 6-18-year-old students.

Authors:  Alizamen Salehifard Jouneghani; Morteza Hashemzadeh Chaleshtori; Abolfazl Khoshdel; Soleiman Kheiri; Effat Farrokhi; Pooran Khalafian; Zahra Aliyari
Journal:  J Res Med Sci       Date:  2017-10-31       Impact factor: 1.852

5.  Prevalence estimates of HIV, syphilis, hepatitis B and C among female sex workers (FSW) in Brazil, 2016.

Authors:  Orlando da Costa Ferreira-Júnior; Mark Drew Crosland Guimarães; Giseli Nogueira Damacena; Wanessa da Silva de Almeida; Paulo Roberto Borges de Souza-Júnior; Célia Landmann Szwarcwald
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

6.  Prevalence of HIV and other sexually transmitted infections and their association with sexual practices and substance use among 2238 MSM in Lebanon.

Authors:  Ayman Assi; Sara Abu Zaki; Jade Ghosn; Nizar Kinge; Jihane Naous; Antoine Ghanem; Diana Abou Abbas; Ziad Bakouny; Georges Azzi; Roland Tomb
Journal:  Sci Rep       Date:  2019-10-22       Impact factor: 4.379

7.  Knowledge, attitudes and practices towards people living with HIV/AIDS in Lebanon.

Authors:  Lara Youssef; Souheil Hallit; Hala Sacre; Pascale Salameh; Michelle Cherfan; Marwan Akel; Mira Hleyhel
Journal:  PLoS One       Date:  2021-03-25       Impact factor: 3.240

8.  Trends & predictors of non-AIDS comorbidities among people living with HIV and receiving antiretroviral therapy in Lebanon.

Authors:  Farouk F Abou Hassan; Mirna A Bou Hamdan; Khalil El Asmar; Jacques E Mokhbat; Nada M Melhem
Journal:  Medicine (Baltimore)       Date:  2022-04-01       Impact factor: 1.817

9.  Epidemiological Profile and Risk Factors for Acquiring HBV and/or HCV in HIV-Infected Population Groups in Nepal.

Authors:  Manjula Bhattarai; Jagat Bahadur Baniya; Nirmal Aryal; Bimal Shrestha; Ramanuj Rauniyar; Anurag Adhikari; Pratik Koirala; Pardip Kumar Oli; Ram Deo Pandit; David A Stein; Birendra Prasad Gupta
Journal:  Biomed Res Int       Date:  2018-01-02       Impact factor: 3.411

10.  Risk factors for HIV infection among female sex workers in Bangui, Central African Republic.

Authors:  Jean De Dieu Longo; Marcel Mbeko Simaleko; Henri Saint-Calvaire Diemer; Gérard Grésenguet; Gilles Brücker; Laurent Belec
Journal:  PLoS One       Date:  2017-11-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.